Clinical Trial Update: Effect of Empagliflozin on Ventricular Repolarization. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial, sponsored by the University of Sao Paulo, evaluating the effect of empagliflozin on ventricular repolarization has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrhythmia
• Coronary Heart Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: University of Sao Paulo | Conditions: Diabetes Mellitus, Type 2, Coronary Heart Disease | Phase 4 | Status: COMPLETED